Opinion
Video
Author(s):
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
Childhood Cancer Survivors May Experience Sooner Aging-Related Disease
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Longer Imbruvica and Venclexta Treatment May Be Beneficial in R/R CLL
The Treatment Journey of a Patient with CLL
Calquence Combo May Improve Outcomes in Chronic Lymphocytic Leukemia
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL